These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4567356)

  • 1. Zinc in serum and urine in hemoblastosis and malignancy.
    Mikac-Devic D; Milic N; Stankovic H
    Acta Med Iugosl; 1972; 26(4):273-80. PubMed ID: 4567356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value and limitations of cytochemical studies of leukocyte metabolism during chemotherapy in patients with malignant blood disorders and hemosarcomas].
    Saracino RT; Lille I; Desplaces A; Clavel B; Bourdin JS
    Sem Hop; 1972 Apr; 48(20):1437-45. PubMed ID: 4340953
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic activities of leukocytes from lymphoproliferative and myeloproliferative disorders during phagocytosis.
    Selvaraj J; McRipley RJ; Sbarra AJ
    Cancer Res; 1967 Dec; 27(12):2287-94. PubMed ID: 5237348
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum folate and serum vitamin B12 in patients with malignant hematologie diseases.
    Hoogstraten B; Baker H; Gilbert HS
    Cancer Res; 1965 Dec; 25(11):1933-8. PubMed ID: 5216688
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis and proteolysis in patients with lymphoma.
    Girolami A; Cliffton EE
    Arch Intern Med; 1966 Jun; 117(6):778-83. PubMed ID: 5327217
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic relationships in familial leukemia and lymphoma.
    Rigby PG; Pratt PT; Rosenlof RC; Lemon HM
    Arch Intern Med; 1968 Jan; 121(1):67-70. PubMed ID: 4864725
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphoreticular tumors in Costa Rica.
    Salas J
    J Natl Cancer Inst; 1973 Jun; 50(6):1657-61. PubMed ID: 4577775
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytochemical and chromatographic study of cellular lipids in lymph node pathology].
    Micu D; Mihailescu E; Astaldi A; Olinescu V
    Haematol Lat; 1970; 13(1):21-30. PubMed ID: 4918653
    [No Abstract]   [Full Text] [Related]  

  • 9. [The primary proliferative processes of the hemopoietic system].
    Introzzi P
    Minerva Med; 1969 Sep; 60(74):3399-450. PubMed ID: 4981171
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of milurit in hyperuricemia in patients with malignant hemopathies].
    Poddubnaia IV; Mansurov AN; Fominykh VG
    Klin Med (Mosk); 1975 Mar; 53(3):94-9. PubMed ID: 1090781
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and pharmacological studies with asparaginase in man.
    Ohnuma T; Holland JF; Freeman A; Sinks LF
    Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic deficiencies in malignant diseases of the lymphoma group and in multiple myeloma].
    Hartl W; Hayduk K
    Arch Klin Med; 1967 Nov; 214(1):54-69. PubMed ID: 4872039
    [No Abstract]   [Full Text] [Related]  

  • 13. [Absorptive insufficiency and albumin metabolism in diffuse tumors of the small intestine].
    Vinogradova MA; Kamaeva NG; Sal'man MM
    Klin Med (Mosk); 1978 Nov; 56(11):51-4. PubMed ID: 364186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytochemistry of hematosarcomas].
    Foa R; Foa C; Muratore R
    Nouv Rev Fr Hematol; 1969; 9(5):727-36. PubMed ID: 4189940
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of the folic activity of the blood during fasting, serum "clearance" and urinary excretion after folic acid administration in treated patients with hemoblastosis].
    Bignotti G; Tognella S; Gennari GP
    Boll Soc Ital Biol Sper; 1964 Dec; 40(23):1495-8. PubMed ID: 4961722
    [No Abstract]   [Full Text] [Related]  

  • 16. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA; Ogston D; Douglas AS
    Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
    [No Abstract]   [Full Text] [Related]  

  • 17. [DNA and RNA synthesis in benign and malignant lymphomas].
    Theml H; Trepel F; Rastetter J; Begemann H
    Klin Wochenschr; 1967 Jun; 45(12):609-18. PubMed ID: 4898318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology of histiocytic sarcomatosis of hemopoietic tissues. Clinico-statistical considerations and remarks on predisposing, premorbid and morbid conditions in 545 cases in certain regions of Lazio].
    Tirasacchi A
    Minerva Med; 1967 Sep; 58(77):3279-85. PubMed ID: 4861511
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent developments in the treatment of hemopoietic and lymphoid neoplasms.
    Flexner JM
    J Tenn Med Assoc; 1977 Jan; 70(1):13-6. PubMed ID: 319299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.